BACKGROUND Dual checkpoint inhibition improves response rates in treatment naive patients with metastatic melanoma compared to monotherapy.However,it confers a
The therapeutic options for patients with metastatic renal cell carcinoma(mRCC)have completely changed during the last ten years.With the sequential use of targ
AIM To investigate the survival impact of clinicopathological factors,including pathological complete response(pCR)and tumor-infiltrating lymphocytes(sTIL)level